• Explore /
  • Poster
  • / Phase III RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: Geographic subgroups.

Phase III RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: Geographic subgroups.

Abstract Poster

Authors

null

Atsushi Ohtsu

Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan

Atsushi Ohtsu , Takayuki Yoshino , Mona M. Wahba , Fabio M. Benedetti , Alfredo Falcone , Rocio Garcia-Carbonero , Josep Tabernero , Alberto F. Sobrero , Marc Peeters , Alberto Zaniboni , Yasuhiro Shimada , Kentaro Yamazaki , Yoshito Komatsu , Howard S. Hochster , Heinz-Josef Lenz , Ben Tran , Robert J. Mayer , Eric Van Cutsem

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01607957

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 646)

DOI

10.1200/jco.2016.34.4_suppl.646

Abstract #

646

Poster Bd #

H7

Abstract Disclosures

Similar Posters

First Author: Atsushi Ohtsu

First Author: Arvind Dasari

First Author: Robert J. Mayer

First Author: Timothy Jay Price